Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis

Journal of Neuroimmunology

Volumn 208, Issue 1-2, 2009, Pages 141-142

  Massa, J ^a   Munger, K L ^a   O'Reilly, E J ^a   Levin, L I ^b   Ascherio, A ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Diphtheria; Etiology; IgG Antibodies; Multiple sclerosis; Prospective studies; Tetanus

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA TOXOID; IMMUNOGLOBULIN G ANTIBODY; TETANUS ANTIBODY; TETANUS TOXOID;

ACTIVE IMMUNIZATION; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DISEASE PREDISPOSITION; HUMAN; HUMORAL IMMUNITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SOLDIER; STUDENT T TEST; TETANUS; TETANUS PROPHYLAXIS;

CASE-CONTROL STUDIES; DIPHTHERIA TOXOID; HUMANS; IMMUNOGLOBULIN G; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; RISK FACTORS; TETANUS TOXOID;

EID: 62549093495     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.01.006     Document Type: Article

References (7)

1. Borrow R., Blamer P., and Roper M.H. The Immunological Basis for Immunization Series Module 3: Tetanus (2006), World Health Organization, Geneva. http://www.who.int/vaccines-documents/DocsPDF07/869.pdf (WHO/EPI). http://www.who.int/vaccines-documents/DocsPDF07/869.pdf
2. Etlinger H.M., Gillessen D., Lahm H.W., Matile H., Schonfeld H.J., and Trzeciak A. Use of prior vaccinations for the development of new vaccines. Science 249 (1990) 423-425
3. Hernan M.A., Alonso A., and Hernandez-Diaz S. Tetanus vaccination and risk of multiple sclerosis: a systematic review. Neurology 67 (2006) 212-215
4. Lamoureux G., Giard N., Jolicoeur R., Toughlian V., and Desrosiers M. Immunological features in multiple sclerosis. Br. Med. J. 1 (1976) 183-186
5. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., and Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Jama 296 (2006) 2832-2838
6. Salmi A., Viljanen M., and Reunanen M. Intrathecal synthesis of antibodies to diphtheria and tetanus toxoids in multiple sclerosis patients. J. Neuroimmunol. 1 (1981) 333-341
7. Vandenbark A.A., Chou Y.K., Whitham R., Mass M., Buenafe A., Liefeld D., Kavanagh D., Cooper S., Hashim G.A., and Offner H. Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat. Med. 2 (1996) 1109-1115